Biomarkers

Lantern Pharma Wins EU Patent for AI-Developed Cancer Therapy

Business WireJuly 22, 2025July 23, 2025

by Business WireJuly 22, 2025July 23, 20250145

Lantern Pharma Inc. (NASDAQ: LTRN), a clinical-stage oncology company leveraging its proprietary RADR® artificial intelligence (AI) platform to accelerate drug discovery, today announced that the European...

Biomarkers

OpenFold Adds New Members to Advance AI for Drug Discovery

Business WireJuly 16, 2025August 7, 2025

by Business WireJuly 16, 2025August 7, 20250158

OpenFold Consortium’s new members will bring privacy-preserving, AI infrastructure and collaboration on proprietary data to the Consortium OpenFold Consortium, an open science initiative advancing foundational...

Biomarkers

datma Launches Federated Biomarker Explorer

PR NewswireJuly 9, 2025July 10, 2025

by PR NewswireJuly 9, 2025July 10, 20250139

Pharma teams can now assess biomarker coverage across datma’s federated network with no cost, contracts, or IT support required. datma, a leader in federated real-world...

Biomarkers

Modella AI and AstraZeneca Partner to Accelerate Oncology Trials

Business WireJuly 3, 2025July 4, 2025

by Business WireJuly 3, 2025July 4, 20250179

Modella AI, a leader in artificial intelligence for life sciences, today announced a multi-year agreement with AstraZeneca. Under the agreement, Modella AI will provide access...

Biomarkers

Empatica Unveils EmbraceMini

Business WireJune 26, 2025June 30, 2025

by Business WireJune 26, 2025June 30, 20250155

Empatica, a pioneer in digital biomarker development and patient monitoring using wearables and AI, today unveiled EmbraceMini, its revolutionary new wearable for clinical trials. EmbraceMini is...

Biomarkers

Neurogen Biomarking Announces Partnership with Aranscia

PR NewswireMay 22, 2025May 24, 2025

by PR NewswireMay 22, 2025May 24, 20250214

Aranscia Diagnostic Laboratory and Technology Solutions Support Neurogen’s Innovative Platform for the Early Detection of Mild Cognitive Impairment (MCI) and Alzheimer’s Dementia Neurogen Biomarking, the...

Biomarkers

Medable Releases New Digital Oncology Trial Offering

Business WireMay 16, 2025May 19, 2025

by Business WireMay 16, 2025May 19, 20250241

Integrated solution with self-service capabilities simplifies trial experience for all Medable Inc., a leading provider of clinical development and eCOA technology, today announced its next-generation...

Biomarkers

GrayMatters Health Announced the Launch of Prism™ Suite

PR NewswireMay 16, 2025May 19, 2025

by PR NewswireMay 16, 2025May 19, 20250265

Innovative Prism™ Platform Now Includes Protocol for Patients with Depression GrayMatters Health (GMH), the pioneers in mental health treatment through digital brain biomarkers, today announced...

Biomarkers

Sapient Launches DynamiQ™ for Drug Discovery and Development

Business WireMay 2, 2025May 2, 2025

by Business WireMay 2, 2025May 2, 20250252

DynamiQ integrates diverse breadth of multi-omic measures with paired real-world data from serial samples to enable deep analysis of patient journeys, disease drivers, and drug...

Biomarkers

MYndspan Appoints Holmusk Founder and CEO Nawal Roy as Strategic Advisor

PR NewswireApril 18, 2025April 21, 2025

by PR NewswireApril 18, 2025April 21, 20250219

Following momentum from its Crowdcube campaign and investment from EMOTIV, MYndspan is deepening its commitment to evidence-based brain health MYndspan, the first company to offer...

Category : Biomarkers

Lantern Pharma Wins EU Patent for AI-Developed Cancer Therapy

OpenFold Adds New Members to Advance AI for Drug Discovery

datma Launches Federated Biomarker Explorer

Empatica Unveils EmbraceMini

Neurogen Biomarking Announces Partnership with Aranscia

Medable Releases New Digital Oncology Trial Offering

GrayMatters Health Announced the Launch of Prism™ Suite

Sapient Launches DynamiQ™ for Drug Discovery and Development

MYndspan Appoints Holmusk Founder and CEO Nawal Roy as Strategic Advisor

RobCo Raises $100 Mn to Scale Its Autonomous Industrial Robotics Platform

Opentrons Global Robotics Chief, James Atwood, Named Chief Executive Officer

Arkose Labs Unleashes Arkose Titan

Wallarm Expands Platform, Company and Leadership to Secure APIs and AI

Backblaze Publishes Q4 2025 Network Stats

RobCo Raises $100 Mn to Scale Its Autonomous...

Opentrons Global Robotics Chief, James Atwood, Named Chief...

Arkose Labs Unleashes Arkose Titan

Wallarm Expands Platform, Company and Leadership to Secure...

Backblaze Publishes Q4 2025 Network Stats

QUICK LINKS

Our Publications